INND (Innerscope Hearing Technologies) 1-Year Sharpe Ratio: -3.53 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Innerscope Hearing Technologies 1-Year Sharpe Ratio?

Innerscope Hearing Technologies INND 1-Year Sharpe Ratio is -3.53 as of Aug. 24, 2026.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-24), Innerscope Hearing Technologies's 1-Year Sharpe Ratio is -3.53.

Innerscope Hearing Technologies  (OTCPK:INND) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Innerscope Hearing Technologies 1-Year Sharpe Ratio Related Terms

INND vs NWCN, NCAP, MOBQ: 1-Year Sharpe Ratio Comparison

For the Medical Instruments & Supplies subindustry, Innerscope Hearing Technologies's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innerscope Hearing Technologies 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innerscope Hearing Technologies's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Innerscope Hearing Technologies's 1-Year Sharpe Ratio falls into.


Innerscope Hearing Technologies 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -3.53 mean?
Innerscope Hearing Technologies (INND) has a 1-Year Sharpe Ratio of -3.53 as of Aug. 24, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Innerscope Hearing Technologies and its competitors.
Is Innerscope Hearing Technologies' 1-Year Sharpe Ratio too high?
Innerscope Hearing Technologies' current 1-Year Sharpe Ratio is -3.53.
How does Innerscope Hearing Technologies' 1-Year Sharpe Ratio compare to NWCN and NCAP?
Innerscope Hearing Technologies' 1-Year Sharpe Ratio of -3.53 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Devices & Instruments company?
A good 1-Year Sharpe Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Innerscope Hearing Technologies and its competitors. Innerscope Hearing Technologies's current 1-Year Sharpe Ratio is -3.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innerscope Hearing Technologies stock overvalued right now?
Innerscope Hearing Technologies (INND) has a current 1-Year Sharpe Ratio of -3.53. The current 1-Year Sharpe Ratio is -3.53. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Innerscope Hearing Technologies (INND), the current 1-Year Sharpe Ratio is -3.53 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innerscope Hearing Technologies Business Description

Address 2151 Professional Drive, Suite 105, Roseville, CA, USA, 95661
Innerscope Hearing Technologies Inc is a manufacturer and distributor of OTC Hearing Aids, Hearing Aid Accessories & Hearing Health-Related Products (Hearing Products) dedicated to addressing the demand for affordable hearing solutions. The company operates retail hearing device clinics in California. InnerScope is focused on leveraging these strategic assets to identify, incubate, and support health-technology ventures positioned for growth in public markets and long-term shareholder value creation.